Safety

CJC-1295

Adverse-event report summary for CJC-1295, drawn from the FDA Adverse Event Reporting System (FAERS).

Total reports
4
Reports flagged serious
4

“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.

Most frequently reported reactions

  1. Abdominal Pain Upper1 reports
  2. Acute Kidney Injury1 reports
  3. Blood Glucose Increased1 reports
  4. Blood Potassium Decreased1 reports
  5. Drug Hypersensitivity1 reports
  6. Dysphagia1 reports
  7. Dyspnoea1 reports
  8. Feeling Abnormal1 reports
  9. Heart Rate Increased1 reports
  10. Hepatic Function Abnormal1 reports
  11. Illness1 reports
  12. Injection Site Abscess1 reports
  13. Myocardial Infarction1 reports
  14. Product Dispensing Error1 reports
  15. Product Preparation Error1 reports

Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.